Inventurus Knowledge Solutions Limited (IKS) AI Stock Analysis

• Market Cap: ₹260.31B
• Dividend Yield: N/A
• Average Volume (3M): 18.99K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.30
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: N/A
• Sector: Services
• Sector Strength: N/A
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 9.00
• Shares Outstanding: 171,573,170
• 10 Day Avg. Volume: 10,831
• 30 Day Avg. Volume: 18,994
• PEG Ratio: 1.45
• Price to Book (P/B): 13.85
• Price to Sales (P/S): 9.31
• P/FCF Ratio: 84.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,569.00
• Price Target Upside: 1.36% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 66 Neutral
• Price Target: ₹1,688.00 ▲(9.05% Upside)

Inventurus Knowledge Solutions shows strong financial performance, which significantly boosts its overall score. However, the absence of valuation data and weak technical indicators dampen the overall outlook. The company's robust growth trajectory and operational efficiency in the healthcare information services industry are key strengths, but caution is advised due to potential volatility in cash management.

Inventurus Knowledge Solutions Limited Business Overview & Revenue Model

Company Description

Inventurus Knowledge Solutions Limited (IKS) is a global provider of revenue cycle management and healthcare solutions. The company operates primarily in the healthcare sector, offering a range of services including medical coding, billing, claims processing, and analytics. IKS leverages technology and expertise to improve operational efficiency and financial outcomes for healthcare providers, payers, and service organizations.

How the Company Makes Money

IKS generates revenue through a variety of services aimed at optimizing the revenue cycle of healthcare organizations. The company earns money by providing outsourced services such as medical coding and billing, which help healthcare providers streamline their operations and improve cash flow. Key revenue streams include fees charged for end-to-end revenue cycle management, consulting services, and technology solutions that enhance healthcare operations. Additionally, IKS forms strategic partnerships with healthcare organizations and technology providers to expand its service offerings and reach in the market, further contributing to its earnings.

Inventurus Knowledge Solutions Limited Financial Statement Overview

Summary

Inventurus Knowledge Solutions demonstrates robust financial health, characterized by strong revenue growth, high profitability margins, and efficient cash flow management. The company effectively manages its leverage, reflected in an improving balance sheet position. Nonetheless, some fluctuations in cash management and operating expenses present opportunities for further optimization.

Income Statement

Inventurus Knowledge Solutions shows strong revenue growth, with a CAGR of over 40% in the last three years. The company maintains high gross profit margins, consistently above 99%, indicating excellent cost management. Net profit margin and EBITDA margin are also robust, suggesting strong operational efficiency. However, the EBIT margin, while solid, shows room for improvement, indicating potential for optimizing operating expenses further.

Balance Sheet

The balance sheet reflects a favorable equity position, with an equity ratio of around 59%, highlighting financial stability. The debt-to-equity ratio decreased significantly from 2024 to 2025, indicating improved leverage management. Return on Equity (ROE) is strong at approximately 27%, showcasing effective use of shareholder funds. However, the company has experienced fluctuations in net debt levels, indicating potential volatility in cash management.

Cash Flow

The cash flow statement reveals solid free cash flow growth, supported by strong operating cash flows, which exceed net income consistently, indicating efficient cash conversion. The free cash flow to net income ratio remains healthy, underscoring the company's ability to generate cash after capital expenditures. However, investing and financing cash flows have shown variability, suggesting periods of significant capital investments and debt adjustments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	26.64B	26.64B	18.17B	10.31B	7.64B
Gross Profit	10.43B	26.63B	18.16B	10.31B	7.64B
EBITDA	7.77B	8.09B	5.61B	3.89B	2.98B
Net Income	4.86B	4.86B	3.70B	3.05B	2.33B
Balance Sheet
Total Assets	30.52B	30.52B	30.28B	9.88B	7.88B
Cash, Cash Equivalents and Short-Term Investments	2.19B	2.19B	4.83B	5.23B	3.47B
Total Debt	8.56B	8.56B	13.11B	523.46M	651.92M
Total Liabilities	12.62B	12.62B	18.70B	1.60B	1.40B
Stockholders Equity	17.90B	17.90B	11.58B	8.29B	6.47B
Cash Flow
Free Cash Flow	2.12B	2.93B	1.77B	2.79B	2.22B
Operating Cash Flow	2.37B	3.18B	2.10B	2.88B	2.33B
Investing Cash Flow	2.84B	2.44B	-11.41B	-1.56B	-824.48M
Financing Cash Flow	-2.74B	-3.89B	7.80B	-1.52B	-585.10M

Inventurus Knowledge Solutions Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ECLERX	74 Outperform	₹212.11B	36.68		0.02%	16.39%	13.26%
CARTRADE	74 Outperform	₹113.16B	72.72		―	-8.98%	390.09%
FSL	66 Neutral	₹246.14B	38.66		1.13%	27.41%	19.27%
IKS	66 Neutral	₹260.31B	―		―	―	―
IONEXCHANG	59 Neutral	₹63.39B	24.22		0.36%	12.99%	1.85%
Sector *	57 Neutral	$1.87B	9.43	8.02%	2.45%	5.38%	-37.86%
HGS	52 Neutral	₹24.33B	22.01		1.33%	-4.50%	-109.54%

Inventurus Knowledge Solutions Limited Corporate Events

Inventurus Knowledge Solutions Limited Updates on SEBI Disclosure Compliance

Inventurus Knowledge Solutions Limited has made a disclosure under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company’s Board of Directors has authorized key managerial personnel to assess the materiality of events or information and ensure necessary disclosures to stock exchanges, aligning with their policy for determining the materiality of events.

Inventurus Knowledge Solutions Announces Key Leadership Changes

Inventurus Knowledge Solutions Limited announced significant changes in its board of directors. Mr. Sachin Gupta has been appointed as the Global CEO of its subsidiary in the USA and as an Additional Director of the company, while resigning from his role as Whole-time Director. Additionally, Ms. Nithya Balasubramanian has been appointed as a Whole-time Director, and Mr. Garheng Albert Kong as an Independent Director, both subject to shareholder approval. These changes are expected to enhance the company’s leadership structure and strategic direction.

Inventurus Knowledge Solutions Appoints Internal Auditor for FY 2025-26

Inventurus Knowledge Solutions Limited has announced the appointment of M/s. KKC & Associates LLP as the internal auditor for the financial year 2025-26, following the recommendation of its Audit Committee. This appointment is part of the company’s compliance with SEBI regulations, and KKC & Associates LLP, a leading chartered accountancy firm in India, will bring its extensive expertise to support Inventurus Knowledge Solutions Limited’s financial oversight.

Inventurus Knowledge Solutions Reports Strong Q1 FY26 Results

Inventurus Knowledge Solutions Limited announced robust financial results for Q1 FY26, with a 16% year-over-year revenue growth and a 59% increase in profit after tax (PAT). The company’s performance highlights the effectiveness of its integrated tech-led care enablement platform, which has driven improvements in EBITDA margins and overall financial health. The results underscore IKS’s commitment to deepening client value, investing in innovation, and scaling its platform to meet the evolving needs of the healthcare ecosystem.

Inventurus Knowledge Solutions Releases Q1 FY26 Financial Results

Inventurus Knowledge Solutions Limited has released an investor presentation detailing the company’s financial results for the quarter ending June 30, 2025. This presentation, which complies with SEBI regulations, is available on the company’s website and has been submitted to both the BSE and NSE for dissemination.

Inventurus Knowledge Solutions Expands Stake in Healthcare Sector

Inventurus Knowledge Solutions Limited announced that its subsidiary, Inventurus Knowledge Solutions Inc, will invest up to USD 17 million to acquire a 48.02% stake in IKS WWMG MSO LLC. This strategic investment aims to elevate the company’s market position, enhance its competitive edge, and support long-term growth by transforming its role in the healthcare sector and increasing the integration of its care enablement platform.

Inventurus Knowledge Solutions Schedules Conference Call on Strategic Investment

Inventurus Knowledge Solutions Limited announced a conference call scheduled for July 3, 2025, to discuss its investment in IKS WWMG MSO LLC through its wholly-owned subsidiary, Inventurus Knowledge Solutions Inc. This move is part of the company’s strategic initiatives to enhance its market position and expand its operations, potentially impacting stakeholders by increasing the company’s influence in the healthcare management sector.